Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Umecrine Cognition AB”

7 pharma patents match "Umecrine Cognition AB" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 7
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 7 pharmaceutical patents matching "Umecrine Cognition AB" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

7 results for “Umecrine Cognition AB” · 30,257 patents in full index Clear search

  1. US 11123351

    Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime

    Umecrine Cognition AB · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  2. US 10603326

    Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oxime

    Umecrine Cognition AB · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted
  3. US 10351589

    3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

    Umecrine Cognition AB · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  4. US 10342804

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted
  5. US 10278977

    Methods for treating hypersomnolence

    Umecrine Cognition AB · Granted May 7, 2019 · Expires May 2, 2039

    granted
  6. US 9801894

    Steroid compound for use in the treatment of hepatic encephalopathy

    Umecrine Cognition AB · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  7. US 9200028

    Steroids having increased water solubility and resistance against metabolism and methods for their production

    Umecrine Cognition AB · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted